Trophos SA appoints Damian Marron

Published: 15-Jul-2008

Trophos SA, a biopharmaceutical company specialising in the discovery and development of drugs for neurological disorders, has appointed Damian Marron as ceo.


Trophos SA, a biopharmaceutical company specialising in the discovery and development of drugs for neurological disorders, has appointed Damian Marron as ceo.

He replaces Antoine Beret who is retiring but will retain a seat on the board.Trophos is currently performing three clinical studies with its novel lead drug candidate TRO19622 - a Phase IIa efficacy trial in painful diabetic neuropathy, an exploratory phase IIa study in patients with NASH and a phase Ib study in Spinal Muscular Atrophy.

You may also like